NCT02648958View on ClinicalTrials.gov

Effect of Dexmedetomidine on Ischemia-Reperfusion Injury in Lower Extremity Operations

NACompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions
Arthroplasty, Replacement
Interventions
DRUG

Dexmedetomidine

The dexmedetomidine group received the dexmedetomidine infusion at a rate of 0.4mg/kg/h after a loading dose of 0.5mg/kg for 10 minutes.

DRUG

normal saline

The control group received the normal saline infusion

Trial Locations (1)

Unknown

Severance hospital, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT02648958 - Effect of Dexmedetomidine on Ischemia-Reperfusion Injury in Lower Extremity Operations | Biotech Hunter | Biotech Hunter